At Eurofins Central Laboratory, our global success is built on the dedication and expertise of talented professionals like Ben Chen, a standout Project Manager based in our Shanghai location. With over 16 years of experience in clinical laboratory operations and project management, Ben plays a critical role in driving the success of global clinical trials through innovative project management … [Read more...] about Spotlight on Ben Chen: Driving Excellence in Project Management at Eurofins Central Laboratory Shanghai
Blog
The Eurofins network expands its BioPharma Product Testing offering in the United States with the acquisition of Infinity Laboratories, Inc.
Eurofins Scientific (EUFI.PA), a global leader in BioPharma Product Testing, announces the closing of its acquisition of Infinity Laboratories, Inc. (“Infinity”). Founded in 1991, Infinity operates eight state-of-the-art laboratories across the United States and employs approximately 100 staff. Infinity’s significant microbiology testing footprint with best-in-class systems provides local services … [Read more...] about The Eurofins network expands its BioPharma Product Testing offering in the United States with the acquisition of Infinity Laboratories, Inc.
Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
Eurofins Discovery, part of the Eurofins network of laboratories and an industry-leading provider of products and services for drug discovery research, today announces the launch of DiscoveryAI SAFIRE (Suite of ADMET Predictions For In Silico Refinement and Evaluation). SAFIRE is an advanced platform that leverages proprietary datasets, artificial intelligence (AI), and machine learning (ML), … [Read more...] about Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
International Women’s Day
As part of our Equality Driving Excellence Initiative, Eurofins is proud to #EmbraceEquity. We stand with International Women’s Day 2023 and imagine a gender-equal world. A world free of bias, stereotypes, and discrimination. A world that's diverse, equitable, and inclusive. A world where difference is valued and celebrated. Together we can forge women's equality. We salute our … [Read more...] about International Women’s Day
Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
Eurofins Scientific (EUFI.PA), the global leader in food, environment, pharmaceutical and cosmetic product testing and a global scientific leader in bioanalytical testing, announces the acquisition of assets to establish a fully-equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad. The acquisition includes a facility capable of supporting large global and Indian pharmaceutical … [Read more...] about Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
Eurofins Central Laboratory China expands its offering to include RSV (respiratory syncytial virus) testing
In collaboration with Eurofins Viracor Biopharma, Eurofins Central Laboratory in Shanghai, China, has expanded its respiratory syncytial virus (RSV) detection capacity since 2021 to support the rapid needs of clients for clinical research on respiratory syncytial virus (RSV). The Eurofins Central Laboratory sites in the Netherlands and Singapore have completed the installation of this … [Read more...] about Eurofins Central Laboratory China expands its offering to include RSV (respiratory syncytial virus) testing
Eurofins Shanghai Central Laboratory resumed testing services on May 7, 2022
In late March, a new wave of COVID-19 hit Shanghai, forcing the city to slow down production. In the warm spring of May, the initial results of the epidemic control were achieved, and it became a top priority for Eurofins Central Laboratory Shanghai to resume work and provide sustainable clinical support services to customers. Under the guidance of the policy and the active communication … [Read more...] about Eurofins Shanghai Central Laboratory resumed testing services on May 7, 2022
Eurofins enhances its clinical and BioPharma service offering in Japan with immune repertoire analysis technology through the acquisition of Repertoire Genesis Inc.
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces the completion of the acquisition of a majority stake in Repertoire Genesis Inc. (“RG”). RG owns a unique and proprietary analytical platform, TCR/BCR (T Cell Receptor/B Cell Receptor) repertoire profiling, that enables scientists to determine the specific … [Read more...] about Eurofins enhances its clinical and BioPharma service offering in Japan with immune repertoire analysis technology through the acquisition of Repertoire Genesis Inc.
Eurofins Technologies announces the launch of RT-PCR kits for the rapid detection of the fast spreading SARS-CoV-2 variant B.1.1.529
Eurofins Technologies continues to innovate and develop a wide range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. In the past days, researchers have identified a new SARS-CoV-2 variant with a concerningly high number of mutations in the spike protein. The variant was first identified in Botswana in November 2021, is spreading rapidly across … [Read more...] about Eurofins Technologies announces the launch of RT-PCR kits for the rapid detection of the fast spreading SARS-CoV-2 variant B.1.1.529
Primary Mitochondrial Myopathy (PMM)
Primary Mitochondrial Myopathy (PMM) Rare diseases are one of the most challenging specialties within clinical trials, due to limited patient populations, lack of historic large scale studies to draw knowledge/clinician expertise and build upon, and frequently, lack of necessary funding to conduct thorough and multi-phased research. That is why Eurofins Central Laboratory is delighted to … [Read more...] about Primary Mitochondrial Myopathy (PMM)